Again logo — Advancing a new industrial era. If you think we’re doomed –...

Again

Advancing a new industrial era. If you think we’re doomed – think Again.

Founded 2020 Denmark Denmark 73 employees Series A Total: $93.60M Biotechnology, Industrial +1

General Information

Company Name Again
Founded Year 2020
Location Denmark Denmark
Founders / Decision Makers
Team member
Employees 73
Industries Biotechnology, Industrial, Manufacturing
Funding Stage Series A
Business Model B2B, D2C, B2B2B
Revenue Model Product Sales, Licensing, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Again. To contact Again, visit again.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Again compare?

A PDF of Again and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Again soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Again

Again, founded in 2020, is a pioneering force in the fields of Biotechnology, Industrial, and Manufacturing. Headquartered in Denmark, the company embodies the spirit captured in its slogan: "Advancing a new industrial era. If you think we’re doomed – think Again."

Again has carved a niche by leveraging millennia-old bacteria in conjunction with state-of-the-art technology to turn CO₂ into carbon-negative chemicals. This transformative biomanufacturing process captures unavoidable industrial carbon outputs, thereby creating emission-free chemicals—a true dual-benefit innovation.

In a significant endorsement of their vision and technology, Again received a €39.40M Series A investment on 17 July 2024. Key investors included Atlantic Labs, GV, HV Capital, ACME Capital, KOMPAS VC, Export and Investment Fund, and CSC Leasing. This influx of capital positions Again well for continued innovation and growth.

Business keywords: carbon utilization, biomanufacturing, carbon negative chemicals, carbon capture, emission-free chemicals, industrial carbon emissions, sustainable industrial practices, climate change mitigation, CO2 conversion, environmental technology, sustainable chemistry, industrial emissions reuse, chemical manufacturing, carbon repurposing, bacterial technology

Services & Products

CO2 conversion to chemicals
Biocatalyst development
AI integration in industrial processes

Target Customers

Industrial manufacturers Chemical buyers CO2 emitters Partners in heavy industry

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €39.40M 7
Atlantic Labs, GV +5
17 Jul 2024
Seed Round $10.00M 3
Atlantic Labs, GV +1
01 Feb 2023
Grant €43.00M 1
Horizon 2020
10 Aug 2022
Pre Seed Round €1.20M 1
Atlantic Labs
01 Nov 2021

Again Alternatives & Competitors

View All Alternatives
Again vs
Solugen
Solugen United States

Decarbonizing the physical world.

Series D
137 employees
Biopharma, Biotechnology
Again vs
HydRegen
HydRegen United Kingdom

Transforming chemical production economics, sustainability and safety with novel biocatalyst platfor...

Seed
19 employees
Biopharma, Biotechnology
Again vs
ChainCraft
ChainCraft The Netherlands

Turning chemistry circular

60 employees
Agriculture, Biotechnology

FAQ About Again

Advancing a new industrial era. If you think we’re doomed – think Again.
Again was founded in 2020.
Again is headquartered in Denmark.
Again operates in Biotechnology, Industrial and Manufacturing. Its work centres on carbon utilization, biomanufacturing, carbon negative chemicals and carbon capture. Its customers include Industrial manufacturers, Chemical buyers and CO2 emitters.
Again has a B2B, D2C and B2B2B business model. Its revenue comes from Product Sales, Licensing and Service Fee.
Again has approximately 73 employees.
Again has completed 4 funding rounds, raising a total of $93.60M. The latest funding stage is Series A.
Again offers: CO2 conversion to chemicals, Biocatalyst development, AI integration in industrial processes.
Top alternatives and competitors to Again include Solugen, HydRegen, ChainCraft, Phytonix Corporation, enginzyme. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Again and Solugen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Again, https://bouncewatch.com/company/again-1, updated 18 May 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes